Feeding Study in Premature Infants
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72205
- The University of Arkansas for Medical Sciences
-
-
Florida
-
Jacksonville, Florida, United States, 32209
- University of Florida
-
Jacksonville, Florida, United States, 32207
- University of Florida
-
Plantation, Florida, United States, 33317
- Plantation General Hospital
-
St. Petersburg, Florida, United States, 33701
- All Children's Hospital
-
-
Illinois
-
Oak Lawn, Illinois, United States, 60453
- Advocate Hope Children's Hospital
-
Park Ridge, Illinois, United States, 60068
- Advocate Lutheran General Children's Hospital
-
-
Nebraska
-
Omaha, Nebraska, United States, 68114
- Children's Hospital
-
-
New York
-
Jamaica, New York, United States, 11432
- Queen's Hospital
-
-
North Carolina
-
Greenville, North Carolina, United States, 27834
- Pitt County Memorial Hospital
-
Wilmington, North Carolina, United States, 28402
- SEAHEC
-
Winston-Salem, North Carolina, United States, 27103
- Forsyth Medical Center
-
-
Virginia
-
Falls Church, Virginia, United States, 22046
- Fairfax Hospital
-
Richmond, Virginia, United States, 23298
- Virginia Commonwealth University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- premature infant
- birth weight less than/equal to 1250 g
- exclusively breast fed
Exclusion Criteria:
- metabolic or chronic disease
- major surgery
- ventilator dependent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: 1
Liquid human milk fortifier
|
Liquid human milk fortifier added to human milk
Other Names:
|
|
ACTIVE_COMPARATOR: 2
Powder human milk fortifier
|
Powder human milk fortifier added to human milk
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Weight gain
Time Frame: 28 days
|
28 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Feeding tolerance
Time Frame: 28 days
|
28 days
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 3379-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.